Exane Derivatives’s Monster Beverage MNST Stock Holding History

Exane Derivatives’s Portfolio MNST Stock Details MNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.02K	Hold	44	–	–	﹤0.01%	504
2022 Q1	$879	Hold	44	–	–	﹤0.01%	810
2021 Q4	$1.06K	Buy	44 +4	+10%	+$89	﹤0.01%	705
2021 Q3	$888	Hold	40	–	–	﹤0.01%	874
2021 Q2	$920	Hold	40	–	–	﹤0.01%	884
2021 Q1	$911	Hold	40	–	–	﹤0.01%	745
2020 Q4	$925	Hold	40	–	–	﹤0.01%	686
2020 Q3	$802	Hold	40	–	–	﹤0.01%	641
2020 Q2	$693	Hold	40	–	–	﹤0.01%	588
2020 Q1	$563	Hold	40	–	–	﹤0.01%	585
2019 Q4	$659	Hold	40	–	–	﹤0.01%	586
2019 Q3	$581	Sell	40 -756	-95%	-$11.5K	﹤0.01%	573
2019 Q2	$12.7K	Sell	796 -10,616	-93%	-$160K	﹤0.01%	444
2019 Q1	$156K	Sell	11,412 -1,284	-10%	-$18.3K	0.03%	253
2018 Q4	$156K	Buy	12,696 +10,400	+453%	+$141K	0.03%	276
2018 Q3	$33.4K	Sell	2,296 -7,112	-76%	-$107K	0.01%	390
2018 Q2	$134K	Buy	9,408 +9,288	+7,740%	+$125K	0.02%	302
2018 Q1	$1.69K	Buy	120 +92	+329%	+$1.44K	﹤0.01%	457
2017 Q4	$443	Sell	28 -1,128	-98%	-$16.9K	﹤0.01%	510
2017 Q3	$16K	Sell	1,156 -1,164	-50%	-$15.7K	﹤0.01%	365
2017 Q2	$28.8K	Sell	2,320 -4,084	-64%	-$49.2K	0.01%	349
2017 Q1	$73.9K	Buy	6,404 +760	+13%	+$8.49K	0.02%	245
2016 Q4	$62.6K	Sell	5,644 -2,048	-27%	-$23.4K	0.01%	281
2016 Q3	$94.1K	Buy	7,692 +6,540	+568%	+$84.9K	0.01%	248
2016 Q2	$15.4K	Hold	1,152	–	–	﹤0.01%	348
2016 Q1	$12.8K	Hold	1,152	–	–	﹤0.01%	400
2015 Q4	$14.3K	Hold	1,152	–	–	﹤0.01%	307
2015 Q3	$13K	Hold	1,152	–	–	﹤0.01%	334
2015 Q2	$12.9K	Hold	1,152	–	–	﹤0.01%	356
2015 Q1	$13.3K	Sell	1,152 -564	-33%	-$5.9K	﹤0.01%	369
2014 Q4	$15.5K	Buy	+1,716	New	+$14.8K	﹤0.01%	400

Other funds holding MNST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Exane Derivatives's MNST Position: Q2 2022 in Review

Exane Derivatives held its Monster Beverage (MNST) position steady in Q2 2022 at 44 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Exane Derivatives first reported a position in MNST in Q4 2014 and has held it in 31 quarters since. The position peaked at $156K in Q4 2018. 772 funds tracked by Wall St. Rank hold MNST as of Q2 2022.

Exane Derivatives held 44 shares of Monster Beverage worth $1.02K as of Q2 2022.
Exane Derivatives left its Monster Beverage share count unchanged in Q2 2022.
Monster Beverage made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #504 holding.
Exane Derivatives first reported a position in Monster Beverage in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's Monster Beverage position peaked at $156K in Q4 2018.
772 funds tracked by Wall St. Rank held Monster Beverage as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.